<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/88285966-BD20-4E44-AF3E-0082C76926BB"><gtr:id>88285966-BD20-4E44-AF3E-0082C76926BB</gtr:id><gtr:name>Department of Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D"><gtr:id>5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D</gtr:id><gtr:name>Nuffield Department of Clinical Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pathology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/88285966-BD20-4E44-AF3E-0082C76926BB"><gtr:id>88285966-BD20-4E44-AF3E-0082C76926BB</gtr:id><gtr:name>Department of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D"><gtr:id>5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D</gtr:id><gtr:name>Nuffield Department of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0C235F4A-B799-41E2-AE3E-885A84E3738E"><gtr:id>0C235F4A-B799-41E2-AE3E-885A84E3738E</gtr:id><gtr:firstName>Geoffrey</gtr:firstName><gtr:otherNames>L</gtr:otherNames><gtr:surname>Smith</gtr:surname><gtr:orcidId>0000-0002-3730-9955</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1000207"><gtr:id>518D3D42-945C-453C-951F-2DB27452896F</gtr:id><gtr:title>Vaccinia virus entry, exit and evasion</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000207</gtr:grantReference><gtr:abstractText>Viruses remain a potent threat to human health as illustrated by the current epidemics caused by influenza virus and human immunodeficiency virus. Basic research on how viruses replicate, spread and evade our immunological defences is important in advancing our understanding of how viruses cause disease and will underpin the development of new vaccines and anti-viral drugs. This proposal concerns vaccinia virus (VACV), a poxvirus and the live vaccine that was used to eradicate smallpox. Although smallpox has been eradicated, VACV continues to be studied because i) it is possible to engineer VACV as a vaccine against other infectious diseases, and ii) the interaction between VACV and the host cell and immune system is providing novel, fundamental information about how viruses cause disease. This application will focus on how VACV enters cells, how new virus particles are transported out of the cell, how these virus particles spread rapidly to other cells, and how VACV evades the immune response to infection. The information obtained will facilitate the engineering of VACV as a safer and more immunogenic vaccine for infectious diseases and cancer.</gtr:abstractText><gtr:technicalSummary>Vaccinia virus (VACV) is the live vaccine that was used to eradicate smallpox. Thereafter, VACV has continued to be studied due to its potential as a live recombinant vaccine for other diseases, and because it is an excellent model for studying virus-host interactions and immune evasion. This project proposal is for renewal of an existing programme grant and the objectives are to study fundamental aspects of VACV biology including entry, egress, spread and immune evasion. 

1. Entry. Studies of VACV entry into cells will focus on the double enveloped extracellular virion. Specifically, we will study how the entry of this virus into cells by a non-fusogenic shedding of the outer envelope is prevented when this virion contacts the A33/A36 complex on the infected cell surface. 

2. Intracellular transport. We will investigate how newly formed VACV particles are transported on microtubules to the cell surface and the roles of proteins E2, 12 and A36 in this process. This work will build on our recent demonstration that F12 is a structural mimic of kinesin light chain (part of the kinesin motor) and proteins E2, F12 and A36 all possess tetratricopeptide repeats that mediate protein:protein interactions. 

3. Virus spread. Recently we have discovered a novel mechanism that VACV uses to spread from cell to cell at a rate 4 times faster than can be explained by the virus replication kinetics. The mechanism involves repulsion of superinfecting virions by the A33 / A36 protein complex so that virus particles are disseminated to distant uninfected cells without replication being required in the intervening cells. This study has redefined how viruses form a plaque and reveals another target for intervention with anti-viral therapy. We will investigate which parts of these proteins are needed, which proteins on the virus surface are required, and test whether soluble fragments of either can diminish virus spread. 

4. Lastly we will investigate immune evasion by VACV, with focus on i) VACV encoded miRNAs that are produced from within the coding region of a VACV mRNA, and ii) an uncharacterised protein, B6, that we hypothesise is a novel chemokine binding protein. The contribution of each to virus virulence and immune evasion will be investigated using appropriate in vitro and in vivo models.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-11-26</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3444983</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biological Sciences Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Functional studies on Golgi anti-apoptotic protein</gtr:description><gtr:id>D0249A8E-8A35-4332-9C9E-034EC19C99DB</gtr:id><gtr:impact>228. Carrara, G., Saraiva, N., Gubser, C., Johnson, B.F. &amp;amp; Smith, G.L. (2012). A six membrane topology for Golgi anti-apoptotic protein and Bax inhibitor-1 (BI-1) provides a model for the transmembrane bax inhibitor containing motif (TMBIM) family. J. Biol. Chem. 287, 15896-15905. 14.3.2012. doi:10.1074/jbc.M111.336149.</gtr:impact><gtr:partnerContribution>electrophysiology</gtr:partnerContribution><gtr:piContribution>Collaboration on the ion channel activity of the Golgi anti-apoptotic protein</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Molecular Virology</gtr:department><gtr:description>Studies on herpes simplex virus morphogenesis</gtr:description><gtr:id>78EC1D7E-8195-43A2-9C82-1A6120AA184C</gtr:id><gtr:impact>229. Hollinshead, M., Johns, H.L., Sayers, C.L., Gonzalez-Lopez, C., Smith, G.L. &amp;amp; Elliott. G. (2012). Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J. published online 18.9.2012 doi:10.1038/emboj.2012.262.</gtr:impact><gtr:partnerContribution>Cell biology of cells infected with herpes simplex virus</gtr:partnerContribution><gtr:piContribution>Microscopy of cells infected with herpes simplex virus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nuffield Department of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Structural Biology</gtr:department><gtr:description>structural and functional studies of vaccinia virus proteins</gtr:description><gtr:id>09ABC6CA-4162-44E5-BF7C-28A3A3FDA129</gtr:id><gtr:impact>Pubmed 17485524, 17681535, 18208323, 18704168</gtr:impact><gtr:partnerContribution>Professor Stuart's lab determine the structure of vaccinia virus proteins and we undertake functional characterisation of the same vaccinia virus proteins.</gtr:partnerContribution><gtr:piContribution>Professor Stuart's lab determine the structure of vaccinia virus proteins and we undertake functional characterisation of the same vaccinia virus proteins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>school visit, Yorkshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>01ADD2F5-11DC-484C-8558-6B9ACF2BF43F</gtr:id><gtr:impact>multiple visits to schools in Peterborough, York, Hertford, Ampleforth. Audiences from

Three schools visited our research labs, Science Museum, Wellcome Foundation, Royal Society and some pupils entered higher education in biology or medicine subsequently.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>visit of school party to research labs</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>1628920A-84BD-4338-B280-2E1F6499FB0C</gtr:id><gtr:impact>visit of school party to research labs, demonstations, lectures, visit to Royal Society (2007), visit to Wellcome Collection (2008), visit to Darwin exhibition at Science Museum (2009)

some of students applied to do medicine or science at imperial college london</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit Hertfordshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BB3829B6-6874-43D7-8ED5-BD081AB1D81D</gtr:id><gtr:impact>100 pupils attended lecture and participated in question and answer session

applications for entry into Cambridge University were submitted</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit and lecture, Oxfordshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2C9B5935-C24C-4686-B257-58C5742F4E58</gtr:id><gtr:impact>100 biology students attended lecture and participated in question and answer session

future visits have been requested. school visit to research lab being scheduled</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme grant G1000207</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>020BCAD6-AE41-4B99-AF86-D86E3B99B240</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman WHO advisory committee on variola virus research</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>BAC1DC4F-EF20-46CF-BAE6-CECA1AE37A5C</gtr:id><gtr:impact>advice on research using live variola virus</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>President, International Union of Microbiological Societies</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>491BC2DE-C58F-43A8-8D4A-E05604248C49</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member Royal Society Science Policy Advisory Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E403AE6D-F857-4CF0-9495-58077A180924</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman Royal Society Committee for Scientific Aspects of International Security</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>432B9F64-FBE9-41A2-938F-A5C95A6746EE</gtr:id><gtr:impact>measures for biosecurity</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9EE1FEEC-D60A-4375-8FD0-EDCC71680D52"><gtr:id>9EE1FEEC-D60A-4375-8FD0-EDCC71680D52</gtr:id><gtr:title>Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ac670efd4d595dec927f9334322eb60"><gtr:id>8ac670efd4d595dec927f9334322eb60</gtr:id><gtr:otherNames>Hollinshead M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50B3BD50-595B-4974-91B8-6F073AFCAD2E"><gtr:id>50B3BD50-595B-4974-91B8-6F073AFCAD2E</gtr:id><gtr:title>Intracellular sensing of viral DNA by the innate immune system.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2da9d54ff08a44d18c5dc8b2a1799059"><gtr:id>2da9d54ff08a44d18c5dc8b2a1799059</gtr:id><gtr:otherNames>Mansur DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D145FAD-111D-4082-A3A3-B251E226701D"><gtr:id>4D145FAD-111D-4082-A3A3-B251E226701D</gtr:id><gtr:title>Vaccinia virus protein C4 inhibits NF-?B activation and promotes virus virulence.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad0c7c4d1a8a4dfe290ff3dd592bc7d4"><gtr:id>ad0c7c4d1a8a4dfe290ff3dd592bc7d4</gtr:id><gtr:otherNames>Ember SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D858817C-5766-44A9-A398-937BC6333B63"><gtr:id>D858817C-5766-44A9-A398-937BC6333B63</gtr:id><gtr:title>A mechanism for induction of a hypoxic response by vaccinia virus.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0891438d816cafe947eb99b11ba8213f"><gtr:id>0891438d816cafe947eb99b11ba8213f</gtr:id><gtr:otherNames>Mazzon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5173A5F-D052-4387-9F42-423752FEA3A3"><gtr:id>D5173A5F-D052-4387-9F42-423752FEA3A3</gtr:id><gtr:title>DNA-PK is a DNA sensor for IRF-3-dependent innate immunity.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/373ea21762568194c3c2ae22dda1a29f"><gtr:id>373ea21762568194c3c2ae22dda1a29f</gtr:id><gtr:otherNames>Ferguson BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C86A2AC-030E-475C-9751-B8E0CB3F72FA"><gtr:id>1C86A2AC-030E-475C-9751-B8E0CB3F72FA</gtr:id><gtr:title>Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/473225cdacfdb90e6e956a114be45abd"><gtr:id>473225cdacfdb90e6e956a114be45abd</gtr:id><gtr:otherNames>Doceul V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3FDAB198-3EFB-4B16-B2CB-80FAFA21AE64"><gtr:id>3FDAB198-3EFB-4B16-B2CB-80FAFA21AE64</gtr:id><gtr:title>Vaccinia virus protein complex F12/E2 interacts with kinesin light chain isoform 2 to engage the kinesin-1 motor complex.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/addd25919af4a9318c221b7381206c2d"><gtr:id>addd25919af4a9318c221b7381206c2d</gtr:id><gtr:otherNames>Carpentier DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2F2EAE8-6626-4845-93CD-E29E7AAC71D9"><gtr:id>E2F2EAE8-6626-4845-93CD-E29E7AAC71D9</gtr:id><gtr:title>Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a3bdbb61b6aeb4c95741c5d5d1dd6d5"><gtr:id>5a3bdbb61b6aeb4c95741c5d5d1dd6d5</gtr:id><gtr:otherNames>Breiman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F07BA633-4A7E-44D2-B1F8-E14769550363"><gtr:id>F07BA633-4A7E-44D2-B1F8-E14769550363</gtr:id><gtr:title>How vaccinia virus has evolved to subvert the host immune response.</gtr:title><gtr:parentPublicationTitle>Journal of structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9e5c2c2d3d6fea623305cf1e13fa45a9"><gtr:id>9e5c2c2d3d6fea623305cf1e13fa45a9</gtr:id><gtr:otherNames>Bahar MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1047-8477</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/312CB07D-1BA9-44D8-AB2A-7506563C6A42"><gtr:id>312CB07D-1BA9-44D8-AB2A-7506563C6A42</gtr:id><gtr:title>A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b18a2d463cba114d1bad64fa2706bf16"><gtr:id>b18a2d463cba114d1bad64fa2706bf16</gtr:id><gtr:otherNames>Peters NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000207</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>